Search for: "TEVA PHARMACEUTICAL INDUSTRIES LIMITED" Results 1 - 20 of 136
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Mar 2024, 9:45 am by Dennis Crouch
Teva Pharmaceuticals USA, Inc. held that in the AIA, Congress did not change the meaning of “on sale” from the pre-AIA statute. [read post]
21 Apr 2023, 9:05 pm by Laura Dolbow
In 2017, Teva Pharmaceuticals submitted an application to market a generic version of Korlym. [read post]
14 Feb 2023, 12:29 pm
</span> </p> <p> <span style="display: initial;"> <br/> </span> </p> <p> <span style="display: initial;"> <span style="display: initial;"> Some well-known patent infringement </span> </span> <a href="https://www.greyb.com/largest-patent-infringement-awards/" target="_blank"… [read post]
19 Apr 2022, 5:05 am by David W.S. Lieberman
The statute also outlines some limited safe harbors for waivers and discounts due to financial need, or other specified policies. [read post]
30 Jul 2021, 7:01 am by Simmons Hanly Conroy
., Teva Pharmaceutical Industries Ltd., and AbbVie Inc’s Allergan unit, which all stand accused of having deceptively marketed their opioid painkillers. [read post]
13 Jul 2021, 6:11 am by Annsley Merelle Ward
Teva Pharmaceutical Industries Ltd and Teva Pharma Belgium NVTeva is the exclusive licensee of EP 2 949 335 (“EP’335”), a European patent relating to a low frequency glatiramer acetate therapy owned by Yeda Research and Development Co. [read post]
3 Aug 2020, 7:02 am by Elizabeth McAuliffe (Bristows)
  He would either have experience of power supply design and application in an industrial context from working for a couple of years in or with industry or would rely on another member of the team with corresponding experience. [read post]
17 Mar 2020, 1:32 pm by Noble McIntyre
One Lot of Topotecan Injection 4 mg/4 mL (1 mg/mL) has been recalled by Teva Pharmaceuticals due to the presence of particulate matter. [read post]
18 Feb 2020, 4:00 am by Martin Kratz
Pfizer Canada ULC, 2020 FC 1, at para. 42. [3] See Sections 27(3)(b) and 28.3 of the Patent Act, RSC 1985, c P-4 [4] Burton Parsons Chemicals, Inc v Hewlett-Packard (Canada) Ltd, [1976] 1 SCR 555 at 563 [5] Apotex Inc v Sanofi-Synthelabo Canada Inc, 2008 SCC 61 at paragraph 37, [2008] 3 SCR 265; see also Bell Helicopter Textron Canada Limitée v Eurocopter, société par actions simplifiée, 2013 FCA 219 at paragraph 65; Mylan Pharmaceuticals ULC v Eli Lilly… [read post]
15 Aug 2019, 9:05 pm by Alana Bevan
District Court for the District of Connecticut against Heritage, Mylan, Teva, and other pharmaceutical manufacturers. [read post]
15 May 2019, 5:27 am by Kluwer Patent blogger
’ ‘Defendant Teva is a consistent participant in the conspiracies identified in this Complaint, but the conduct is pervasive and industry-wide. [read post]
30 Apr 2019, 7:22 am
  As the legislation is written it covers every type of industry whereas in reality different issues arise. [read post]
15 Oct 2018, 7:05 am by Deborah Heller
Justice Kavanaugh being seated prior to the second week of oral arguments in October means that most of the cases on the docket in the October Term will be heard by a complete Court of 9 Justices; thus avoiding the dreaded 4-4 split. [read post]
12 Oct 2018, 1:24 pm by Lawrence B. Ebert
Delaware of invalidity of claims:Plaintiffs-Appellants Teva Pharmaceuticals USA,Inc., Teva Pharmaceutical Industries, Ltd., Teva Neuroscience,Inc., and Yeda Research and Development Co. [read post]
2 Feb 2018, 1:31 pm by Gregory Sephton
Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries, Ltd., Case 2016-1284, 2016-1787 (Fed. [read post]